Keyphrases
Human Hepatocellular Carcinoma
100%
CD80
100%
CD86
100%
B7-1
100%
B7-2
100%
Costimulatory Molecules
100%
Hep3B Cells
33%
Human Leukocyte Antigen Class I
25%
Quantitative PCR
16%
Complementary DNA (cDNA)
16%
Expression Level
16%
Flow Cytometric Analysis
16%
Human Hepatocellular Carcinoma Cell Line
16%
Gene Transfer
8%
Plasmid
8%
Costimulation
8%
Messenger RNA (mRNA)
8%
CD28
8%
Interferon-y
8%
Tumor Immunity
8%
Cytotoxic T Lymphocytes
8%
Cell Surface
8%
Interferon-α (IFN-α)
8%
T-cell Mediated
8%
Dose Effect
8%
MRNA Level
8%
Cytolytic Activity
8%
Interferon Treatment
8%
Chain Flow
8%
Mixed Lymphocyte Culture
8%
Associated Antigen
8%
Mixed Tumor
8%
Immunogene Therapy
8%
Tumor Cell Culture
8%
Cross-cultural Analysis
8%
Immunology and Microbiology
Interferon Type I
100%
CD80
100%
CD86
100%
Human Leukocyte Antigen
100%
Reverse Transcription Polymerase Chain Reaction
66%
Hepatocellular Carcinoma Cell Line
66%
T Cell
66%
Cell Line
33%
Gene Immunotherapy
33%
CD28
33%
Plasmid
33%
Cell Surface
33%
Gene Transfer
33%
Mixed Lymphocyte Culture
33%
Tumor Cell Culture
33%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Human Leukocyte Antigen
100%
Interferon
100%
Reverse Transcription Polymerase Chain Reaction
66%
Hepatocellular Carcinoma Cell Line
66%
Complementary DNA
66%
T Cell
33%
Receptor
33%
T Lymphocyte
33%
Cell Surface
33%
Gene Transfer
33%
Tumor Cell Culture
33%
Mixed Lymphocyte Culture
33%
Gene Immunotherapy
33%
Cell Line
33%
Plasmid
33%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Leukocyte Antigen
75%
Interferon
75%
Complementary DNA
50%
Immunoglobulin
25%
Receptor
25%
Neoplasm
25%